By Uduak Grace Thomas

Collaborative Drug Discovery recently received a Phase I Small Business Innovation Research grant from the National Library of Medicine that it will use to develop a method of securely sharing in silico drug models that can be used to predict the absorption, distribution, metabolism, excretion, and toxicity of possible treatments for tuberculosis.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Browse our free articles
You can still register for access to our free content.